The Neuro-Oncology Program located at the Donald H. Ruttenberg Center of the Tisch Cancer Institute in the Norma Hess Center for Science and Medicine provides a multidisciplinary approach to the care and treatment of patients with brain tumors, metastases to the nervous system, spinal cord tumors, and the neurological complications of cancer and its treatment.
The team works closely with members of other subspecialties, such as Neurosurgery, Medical Oncology, Radiology, Neuropathology, Rehabilitation Medicine, and Palliative Care, to provide comprehensive treatment. In addition, in a collaborative effort with researchers, new treatments are being developed and experimental agents are tested in clinical trials.
Expert Diagnosis and Management
The Neuro-Oncology Program at The Mount Sinai Hospital offers the latest in diagnosis and treatment for people with both common and rare brain tumors, metastases to the brain or spinal cord, and the neurological complications resulting from cancer. Diagnostic services include advanced imaging technologies and pathology analysis of tumor samples.
Our neuro-oncologist designs and oversees the appropriate chemotherapy, target therapy, angiogenesis inhibitors, and immunotherapy for each patients, as well as coordinates personalized patient care that may include the expertise of neurosurgeons, neuroradiologists, neuropathologists, radiation oncologists, oncologists, oncology nurse practitioners, socials workers, and palliative care.
Adilia Hormigo, MD, PhD
Neuro-Oncologist and Director
Dr. Hormigo specializes in the care of patients with primary brain tumors, central nervous system metastases, and the neurological complications of cancer and its treatment. Dr. Hormigo completed a residency in Neurology in Portugal, at the University Hospital of Lisbon Medical School and Portuguese Oncological Institute, as well as at New York Presbyterian-Weill Medical College of Cornell University and Memorial Sloan-Kettering Cancer Center where she completed both research and clinical neuro-oncology fellowships under Jerome B. Posner and served as Assistant Professor of Neurology and Assistant Member. While there, she trained a number of fellows, many of whom are now junior faculty in leading programs of neuro-oncology in the country and abroad. Dr. Hormigo received her MD with honors from the University of Lisbon Medical School in Portugal, and her PhD from New York University.
Prior to joining the Mount Sinai team, Dr. Hormigo served as Associate Professor in the Departments of Neurology, Oncology, Neurosurgery, and the Center for Translational Neuromedicine at the University of Rochester Medical Center. Her translational research has focused on studying tumor microenvironment and developing serum markers and more effective treatments for patients with brain tumors.
Division of Neuro-Oncology
1470 Madison Avenue
New York, NY 10029